Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 2/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ADIPOR2 | Q86V24 | 1/20 | 0.51 |
| ▸ | ADIPOR1 | Q96A54 | 1/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2983320 | 1.00 | POLB (0.59) | POLBRAB9ASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL2985500 | 0.93 | ATF4 (0.57) | POLBRAB9ASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL2982759 | 0.93 | ATF4 (0.57) | POLBRAB9ASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL2987821 | 0.92 | ATF4 (0.58) | POLBRAB9ASMN1; SMN2ALDH1A1LMNA | |
| SCHEMBL2972836 | 0.89 | MEN1 (0.50) | POLBRAB9ASMN1; SMN2MEN1KMT2A | |
| SCHEMBL2987472 | 0.88 | NPSR1 (0.48) | POLBRAB9AALDH1A1MEN1KMT2A | |
| SCHEMBL4052907 | 0.81 | KMT2A (0.51) | ALDH1A1MEN1KMT2A | |
| SCHEMBL2989191 | 0.81 | TSHR (0.49) | POLBRAB9ASMN1; SMN2ALDH1A1MEN1 | |
| SCHEMBL2982591 | 0.79 | TSHR (0.50) | POLBRAB9ASMN1; SMN2ALDH1A1KMT2A | |
| SCHEMBL5159085 | 0.79 | ATF4 (0.41) | POLBRAB9ASMN1; SMN2ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7786328-B2 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2010-08-31 | — | — | US | claimed |
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2007-12-06 | — | — | US | claimed |
| US-7786328-B2 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2010-08-31 | — | — | US | disclosed |
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | GRUENENTHAL GMBH (DE) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281954-A1 | Cyclohexyl-1,4-diamine compounds | DPYD, PKD1, AOC1 | POLB 1844/4885RAB9A 516/4885SMN1; SMN2 895/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.